CardioVascular BioTherapeutics, Inc. 4
4 · CardioVascular BioTherapeutics, Inc. · Filed Mar 10, 2008
Insider Transaction Report
Form 4
Priemer Wolfgang
Director
Transactions
- Sale
common stock
2008-03-07$1.28/sh−5,000$6,400→ 14,800,000 total(indirect: WOBEMA, BV, as Director) - Sale
common stock
2008-03-10$1.18/sh−5,000$5,900→ 14,795,000 total(indirect: WOBEMA, BV, as Director) - Sale
common stock
2008-03-06$1.26/sh−5,000$6,300→ 14,805,000 total(indirect: WOBEMA, BV, as Director)
Holdings
- 1
common stock
Footnotes (1)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan entered into as of 9/10/07 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.